Appointment(s):

Associate Professor
Researcher at the Environmental Health Sciences Research Center

College(s): Engineering and Pharmacy

When patients with cystic fibrosis or other disorders that weaken the immune system are infected with bacteria like Pseudomonas aeruginosa, it can lead to ongoing, decades-long infections and even death. That’s why Jennifer Fiegel is researching ways to develop more effective, inhalable treatments for respiratory infections. With a research award from the National Institutes of Health, Fiegel hopes to identify a unique combination of compounds to more effectively eradicate P. aeruginosa, and her team’s preliminary results already show success working on a simple strain of the bacteria in the lab as well as clinical isolates from patients with cystic fibrosis.

Banner location: not on display—